Prolactinoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} {{AE}} {{Anmol}} | {{CMG}} {{AE}} {{Anmol}}, {{Faizan}} | ||
==Overview== | ==Overview== | ||
In 1970, [[Prolactin]] was discovered in human by sensitive [[bioassay]].<ref name="Frantz1978">{{cite journal|last1=Frantz|first1=Andrew G.|title=Prolactin|journal=New England Journal of Medicine|volume=298|issue=4|year=1978|pages=201–207|issn=0028-4793|doi=10.1056/NEJM197801262980408}}</ref> | In 1970, [[Prolactin]] was discovered in human by sensitive [[bioassay]].<ref name="Frantz1978">{{cite journal|last1=Frantz|first1=Andrew G.|title=Prolactin|journal=New England Journal of Medicine|volume=298|issue=4|year=1978|pages=201–207|issn=0028-4793|doi=10.1056/NEJM197801262980408}}</ref> |
Revision as of 12:43, 20 July 2017
Prolactinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Prolactinoma historical perspective On the Web |
American Roentgen Ray Society Images of Prolactinoma historical perspective |
Risk calculators and risk factors for Prolactinoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]
Overview
In 1970, Prolactin was discovered in human by sensitive bioassay.[1]
Historical Perspective